Probiotics, Immunomodulation, and Health Benefits
- 31 December 2007
- book chapter
- review article
- Published by Springer Science and Business Media LLC in Advances in experimental medicine and biology
- Vol. 606, 423-454
- https://doi.org/10.1007/978-0-387-74087-4_17
Abstract
Probiotics are defined as live microorganisms that, when administered in adequate amount, confer a health benefit on the host. Amongst the many benefits associated with the consumption of probiotics, modulation of the immune system has received the most attention. Several animal and human studies have provided unequivocal evidence that specific strains of probiotics are able to stimulate as well as regulate several aspects of natural and acquired immune responses. There is also evidence that intake of probiotics is effective in the prevention and/or management of acute gastroenteritis and rotavirus diarrhoea, antibiotic-associated diarrhoea and intestinal inflammatory disorders such as Crohn’s disease and pouchitis, and paediatric atopic disorders. The efficacy of probiotics against bacterial infections and immunological disorders such as adult asthma, cancers, diabetes, and arthritis in humans remains to be proven. Also, major gaps exist in our knowledge about the mechanisms by which probiotics modulate immune function. Optimum dose, frequency and duration of treatment required for different conditions in different population groups also remains to be determined. Different probiotic strains vary in their ability to modulate the immune system and therefore efficacy of each strain needs to be carefully demonstrated through rigorously designed (randomised, doubleblind, placebo-controlled) studies. This chapter provides an over view of the immunomodulatory effects of probiotics in health and disease, and discusses possible mechanisms through which probiotics mediate their disparate effects.Keywords
This publication has 128 references indexed in Scilit:
- Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to dateNeurogastroenterology & Motility, 2006
- Probiotics in the treatment of Japanese cedar pollinosis: a double‐blind placebo‐controlled trialClinical and Experimental Allergy, 2006
- Host–bacterial interactions in inflammatory bowel diseaseClinical Science, 2004
- Scientific basis of biomarkers and benefits of functional foods for reduction of disease risk: cancerBritish Journal of Nutrition, 2002
- Allergy development and the intestinal microflora during the first year of lifeJournal of Allergy and Clinical Immunology, 2001
- Genetics of Mouse Behavior: Interactions with Laboratory EnvironmentScience, 1999
- A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian childrenThe Journal of Pediatrics, 1999
- Immune and Clinical Impact of Lactobacillus acidophilus on AsthmaAnnals of Allergy, Asthma & Immunology, 1997
- Effect of the oral administration of Lactobacillus brevis subsp. coagulans on interferon-alpha producing capacity in humans.Journal of the American College of Nutrition, 1996
- Oral bacteriotherapy for viral gastroenteritisDigestive Diseases and Sciences, 1994